Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Endocrinology
•
Adrenal Disorders
•
General Endocrinology
What is your approach to differentiating pseudo-Cushing's state from Cushing's syndrome?
Related Questions
In what clinical scenarios should we use the 2-day 2mg DST instead of the 1mg overnight DST for screening of Cushing syndrome?
What clinical sign or symptom do you consider to be the most specific for Cushing syndrome?
When performing adrenal vein sampling, is calculating selectivity index using androstenedione superior to using cortisol alone for determining successful catheterization?
How do you approach monitoring for autoimmune disorders in patients with surgical remission of Cushing’s disease, given the higher incidence of autoimmune disease in this population?
How does contralateral suppression of more than 50% with cosyntropin during adrenal venous sampling influence your decision to recommend adrenalectomy in patients with primary aldosteronism?
Does norethindrone suppress FSH, LH completely?
In your practice, when do you opt to treat unilateral primary hyperaldosteronism medically rather than surgically?
What strategies do you use to prevent overcorrection of serum sodium in patients with severe hyponatremia and adrenal insufficiency when initiating glucocorticoid therapy?
Would you expect an oral sodium loading test to be positive in secondary hyperaldosteronism or pseudohyperaldosteronism?
Do you use the homeostatic model assessment (HOMA) to assess for insulin resistance and change your clinical management of patients?